Dorsey Wright & Associates Has $920,000 Stake in Tenet Healthcare Co. (NYSE:THC)

Dorsey Wright & Associates lessened its stake in Tenet Healthcare Co. (NYSE:THCFree Report) by 24.4% during the fourth quarter, Holdings Channel reports. The firm owned 7,291 shares of the company’s stock after selling 2,349 shares during the period. Dorsey Wright & Associates’ holdings in Tenet Healthcare were worth $920,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Norges Bank purchased a new position in Tenet Healthcare during the 4th quarter worth $190,819,000. Wealthfront Advisers LLC bought a new stake in Tenet Healthcare in the 4th quarter worth about $69,059,000. Geode Capital Management LLC lifted its position in shares of Tenet Healthcare by 23.6% during the 3rd quarter. Geode Capital Management LLC now owns 2,044,667 shares of the company’s stock worth $339,893,000 after buying an additional 390,316 shares in the last quarter. Raymond James Financial Inc. purchased a new position in shares of Tenet Healthcare in the 4th quarter worth approximately $49,001,000. Finally, Iron Triangle Partners LP purchased a new stake in shares of Tenet Healthcare during the third quarter valued at approximately $51,346,000. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Stock Down 0.9 %

Shares of NYSE:THC opened at $133.17 on Friday. The company has a debt-to-equity ratio of 2.25, a current ratio of 1.78 and a quick ratio of 1.70. Tenet Healthcare Co. has a one year low of $90.03 and a one year high of $171.20. The company has a market cap of $12.67 billion, a price-to-earnings ratio of 4.13, a PEG ratio of 1.02 and a beta of 2.06. The firm has a fifty day moving average price of $132.43 and a two-hundred day moving average price of $142.42.

Tenet Healthcare (NYSE:THCGet Free Report) last announced its earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share for the quarter, topping analysts’ consensus estimates of $2.95 by $0.49. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%. Analysts anticipate that Tenet Healthcare Co. will post 12.24 EPS for the current fiscal year.

Insider Buying and Selling at Tenet Healthcare

In other news, Director J Robert Kerrey sold 9,525 shares of Tenet Healthcare stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total transaction of $1,194,720.75. Following the completion of the sale, the director now directly owns 27,378 shares of the company’s stock, valued at approximately $3,434,022.54. The trade was a 25.81 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 0.93% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. Cantor Fitzgerald restated an “overweight” rating and issued a $177.00 price objective on shares of Tenet Healthcare in a research note on Thursday, February 13th. StockNews.com upgraded shares of Tenet Healthcare from a “hold” rating to a “buy” rating in a report on Thursday, March 13th. Truist Financial reduced their target price on shares of Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating for the company in a research report on Monday, January 6th. The Goldman Sachs Group downgraded Tenet Healthcare from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $196.00 to $140.00 in a research note on Monday, December 16th. Finally, Barclays lowered their target price on Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating on the stock in a research note on Thursday, February 13th. Three analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Tenet Healthcare has a consensus rating of “Moderate Buy” and an average target price of $166.41.

Get Our Latest Analysis on Tenet Healthcare

Tenet Healthcare Company Profile

(Free Report)

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Featured Stories

Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Co. (NYSE:THCFree Report).

Institutional Ownership by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.